3TC

4-AMINO-1-[(2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]PYRIMIDIN-2(1H)-ONE

Created:	2006-10-26
Last modified:	2020-06-05

Find Related PDB Entry
1 entries where 3TC is found as a standalone ligand

Help Find related ligands:
Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Help

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	26
Chiral Atom Count	2
Bond Count	27
Aromatic Bond Count	6

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	4-AMINO-1-[(2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]PYRIMIDIN-2(1H)-ONE
Synonyms	(-)-L-2',3'-DIDEOXY-3'-THIACYTIDINE; LAMIVUDINE; EPIVIR
Systematic Name (OpenEye OEToolkits)	4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
Formula	C₈ H₁₁ N₃ O₃ S
Molecular Weight	229.256
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	O=C1N=C(N)C=CN1C2OC(SC2)CO
SMILES	CACTVS	3.341	NC1=NC(=O)N(C=C1)[CH]2CS[CH](CO)O2
SMILES	OpenEye OEToolkits	1.5.0	C1C(OC(S1)CO)N2C=CC(=NC2=O)N
Canonical SMILES	CACTVS	3.341	NC1=NC(=O)N(C=C1)[C@@H]2CS[C@H](CO)O2
Canonical SMILES	OpenEye OEToolkits	1.5.0	C1[C@H](O[C@H](S1)CO)N2C=CC(=NC2=O)N
InChI	InChI	1.03	InChI=1S/C8H11N3O3S/c9-5-1-2-11(8(13)10-5)6-4-15-7(3-12)14-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7+/m0/s1
InChIKey	InChI	1.03	JTEGQNOMFQHVDC-NKWVEPMBSA-N

Drug Info: DrugBank

DrugBank ID	DB00709
Name	Lamivudine
Groups	approved investigational
Description	A reverse transcriptase inhibitor and zalcitabine analog in which a sulfur atom replaces the 3' carbon of the pentose ring. It is used to treat Human Immunodeficiency Virus Type 1 (HIV-1) and hepatitis B (HBV).
Synonyms	(-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine beta-L-2',3'-Dideoxy-3'-thiacytidine beta-L-3'-Thia-2',3'-dideoxycytidine 2',3'-Dideoxy-3'-thiacytidine Lamivudin 3TC Lamivudinum Lamivudina Lamivudine (-)-2'-Deoxy-3'-thiacytidine 3'-Thia-2',3'-dideoxycytidine
Brand Names	Auro-lamivudine Delstrigo LAMIVUDINE and ZIDOVUDINE Lamivudine Teva Pharma B.V. Abacavir, Lamivudine and Zidovudine Combivir Apo-lamivudine Symfi Mylan-abacavir/lamivudine Cimduo Auro-lamivudine/zidovudine Apo-zidovudine-lamivudine-nevirapine Apo-lamivudine-zidovudine Mint-abacavir/lamivudine PMS-abacavir-lamivudine Dovato Lamivudine, Nevirapine, and Zidovudine Kivexa Jamp Lamivudine / Zidovudine 3tc Lamivudine/zidovudine Teva Zeffix Lamivudine and Zidovudine Apo-abacavir-lamivudine Tablets Apo-abacavir-lamivudine-zidovudine Abacavir and Lamivudine Jamp Abacavir / Lamivudine Symfi Lo Epzicom Abacavir and lamivudine Abacavir Sulfate, Lamivudine and Zidovudine Triumeq PD Apo-abacavir-lamivudine Lamivudine Oral Solution Lamivudine Teva Lamivudine Dutrebis Triumeq Temixys Epivir Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Apo-lamivudine Hbv Jamp Lamivudine Hbv Epivir Hbv Jamp Lamivudine Lamivudine Zidovudine Trizivir Heptovir Teva-lamivudine/zidovudine Teva-abacavir/lamivudine Auro-abacavir/lamivudine
Indication	For the treatment of HIV infection and chronic hepatitis B (HBV).
Categories	Agents Causing Muscle Toxicity Anti-HIV Agents Anti-Infective Agents Anti-Retroviral Agents Antiinfectives for Systemic Use Antiviral Agents Antivirals for Systemic Use Antivirals used in combination for the treatment of HIV infections BCRP/ABCG2 Substrates Deoxycytidine Deoxyribonucleosides Dideoxynucleosides Direct Acting Antivirals Drugs that are Mainly Renally Excreted Enzyme Inhibitors Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor Nucleic Acid Synthesis Inhibitors Nucleic Acids, Nucleotides, and Nucleosides Nucleoside and Nucleotide Reverse Transcriptase Inhibitors Nucleoside Reverse Transcriptase Inhibitors Nucleosides OAT1/SLC22A6 Substrates OCT1 substrates OCT2 Substrates P-glycoprotein substrates Pyrimidine Nucleosides Pyrimidines Reverse Transcriptase Inhibitors
ATC-Code	J05AR27 J05AR02 J05AR25 J05AR11 J05AR07 J05AR01 J05AR13 J05AR12 J05AR24 J05AR04 J05AR16 J05AR05 J05AF05
CAS number	134678-17-4

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Reverse transcriptase/RNaseH	PISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKI...	unknown	inhibitor
DNA	-	unknown	binder
Protein P	MPLSYPHFRKLLLLDDEAGPLEEELPRLADEDLNRRVAADLNLQLPNVSI...	unknown	inhibitor
Deoxycytidine kinase	MATPPKRSCPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLCEDWEV...	unknown	substrate
UMP-CMP kinase	MKPLVVFVLGGPGAGKGTQCARIVEKYGYTHLSAGELLRDERKNPDSQYG...	unknown	substrate
Phosphoglycerate kinase 1	MSLSNKLTLDKLDVKGKRVVMRVDFNVPMKNNQITNNQRIKAAVPSIKFC...	unknown	substrate
Nucleoside diphosphate kinase A	MANCERTFIAIKPDGVQRGLVGEIIKRFEQKGFRLVGLKFMQASEDLLKE...	unknown	substrate
Nucleoside diphosphate kinase B	MANLERTFIAIKPDGVQRGLVGEIIKRFEQKGFRLVAMKFLRASEEHLKQ...	unknown	substrate
Choline-phosphate cytidylyltransferase A	MDAQCSAKVNARKRRKEAPGPNGATEEDGVPSKVQRCAVGLRQPAPFSDE...	unknown	substrate
Ethanolamine-phosphate cytidylyltransferase	MIRNGRGAAGGAEQPGPGGRRAVRVWCDGCYDMVHYGHSNQLRQARAMGD...	unknown	substrate
5'(3')-deoxyribonucleotidase, cytosolic type	MARSVRVLVDMDGVLADFEAGLLRGFRRRFPEEPHVPLEQRRGFLAREQY...	unknown	substrate
Serum albumin	MKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIA...	unknown
Multidrug resistance-associated protein 1	MALRGFCSADGSDPLWDWNVTWNTSNPDFTKCFQNTVLVWVPCFYLWACF...	unknown	inhibitor
Solute carrier family 22 member 6	MAFNDLLQQVGGVGRFQQIQVTLVVLPLLLMASHNTLQNFTAAIPTHHCR...	unknown	substrate
ATP-binding cassette sub-family G member 2	MSSSNVEVFIPVSQGNTNGFPATASNDLKAFTEGAVLSFHNICYRVKLKS...	unknown	substrate
Solute carrier family 22 member 1	MPTVDDILEQVGESGWFQKQAFLILCLLSAAFAPICVGIVFLGFTPDHHC...	unknown	substrate
Solute carrier family 22 member 2	MPTTVDDVLEHGGEFHFFQKQMFFLLALLSATFAPIYVGIVFLGFTPDHR...	unknown	substrate
Solute carrier family 22 member 3	MPSFDEALQRVGEFGRFQRRVFLLLCLTGVTFAFLFVGVVFLGTQPDHYW...	unknown	substrate
P-glycoprotein 1	MDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLY...	unknown	substrate
Multidrug resistance-associated protein 4	MLPVYQEVKPNPLQDANLCSRVFFWWLNPLFKIGHKRRLEEDDMYSVLPE...	unknown	substrate
Canalicular multispecific organic anion transporter 2	MDALCGSGELGSKFWDSNLSVHTENPDLTPCFQNSLLAWVPCIYLWVALP...	unknown	substrate
Canalicular multispecific organic anion transporter 1	MLEKFCNSTFWNSSFLDSPEADLPLCFEQTVLVWIPLGYLWLLAPWQLLH...	unknown
View More

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682